This document discusses quality assurance in the pharmaceutical industry. It defines quality assurance as the planned activities to provide confidence that a product or service will meet requirements. The basic principles of QA are that quality must be designed into the product and cannot be inspected in afterwards. Key components of a QA system include following GMP, having written production and control procedures, managing materials and processes, inspecting finished products, conducting self-inspections, and having top management responsibility.
2. Contents
• Introduction
• Quality Assurance
Introduction
Definitions
Basic Principles of QA
Characteristics of QA
Components of QA
3. Quality Assurance
• Quality assurance is a wide ranging concept
covering all matters that individually and
collectively influence the quality of product.
• It is the arrangements made with the object of
ensuring that pharmaceutical products are of the
quality required for the intended use.
• Assurance of product quality is derived from
careful attention of factors including selection of
quality parts and materials, adequate product
and process design, control of the process, and
in-process and end-product testing.
4. Definitions
According to WHO (World Health Organization):
“QA is the activity of providing evidence needed to establish
confidence among all concerned that quality related
activities are being performed effectively.”
According to ISO 9000:
“All those planned and systematic activities implemented to
provide adequate confidence that an entity will fulfill
requirements for quality.”
5. Definitions
“Quality Assurance is verifying that quality control
procedures are being followed to provide confidence
that a product or service will satisfy client
requirements”. (Edwards and Kelcey)
“Quality Assurance is a comprehensive written
plan and activities that documents the progress of a
project design for example from initial planning
through final plans”.
6. Basic Principles of QA
• Quality, safety and effectiveness must be
designed and built into the product.
• Quality cannot be inspected or tested into the
finished product.
• Each step of manufacturing process must be
controlled to maximize the probability that
the finished product meets all quality design
specifications.
8. Identity
• The regulatory authorities consider
identity as the product identity. i.e.
the unique identity of a given
product, which primarily relates to
the name and content of the product.
• Product identity may be referred to
as:
– Name of the Product,
– Type of formulation
– Name of quantity of API in a unit dose
10. Strength
• Regulatory authorities consider this
mainly to the strength of the
pharmaceutical unit dose as claimed
on label.
• Ex: “each tablet contains 500mg of
Paracetamol”
• What was assay/ potency of API?
• Does each unit dose contain the
claimed amount?
• Does each primary pack contains
claimed units?
• Does each secondary / tertiary pack
contains desired primary / secondary
packs in it?
11. Safety
• The regulatory authorities refer it to
the safety of ultimate user or patient.
• What happen? And what should
happen? When pharmaceutical
product consumed by patient.
– First, he gets no desired effect
– Second, he gets partial desired effect.
– Third, he gets undesired, unexpected
effects. (i.e. unknown side effects).
– Fourth, he get expected undesired
effects. (i.e. known side effects).
– Fifth, he gets desired effects
12. Purity
• The product is free from
any cross contamination.
• A contaminant in this case
may be defined as the
presence of any undesired
/unexpected material in
the product.
13. Efficacy
• Any product which meets the above four
characteristics will have the desired
therapeutic efficacy of product.
14. Components of QA
• Pharmaceutical products are
designed and developed in a way
that takes account of the
requirement of GMP, GLP, GVP,
GCP etc.
15. Components of QA
• Production and control operations are clearly
specified in a written form and GMP requirements
are adopted.
• Managerial responsibilities are clearly described.
16. Components of QA
• Arrangements are made for manufacture, supply and
use of correct starting and packaging materials.
• All necessary controls on starting materials,
intermediate products and bulk products and other
in process controls, calibrations and validation are
carried out.
17. Components of QA
• The finished products is correctly processed
and checked according to defined procedures.
18. Components of QA
• Pharmaceutical products are not sold or
supplied before authorized person certified
that each production batch has been
produced and controlled accordance with
requirement.
19. Components of QA
• Self inspection or quality audit that regularly
appraise the Q. A. system.
20. Components of QA
• Production environment and service to
production operations are monitored.
• Deviations are adequately recorded,
investigated and responded.
21. RESPONSIBILITIES OF QA
In particular the top management is responsible
for:
• Providing leadership
• Structure the organization.
• Build quality systems to meet the requirements.
• Establishment policies, objectives and plans.
• Review the system.